Literature DB >> 31646338

Ending the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits.

Robert W Eisinger1, Gregory K Folkers1, Anthony S Fauci1.   

Abstract

Unprecedented basic and clinical biomedical research advances over the past 4 decades have led to the development of "toolkits" of highly effective interventions for preventing and treating human immunodeficiency virus (HIV). Despite many successes in decreasing the incidence and mortality of HIV, major challenges remain in the goal of ending the HIV pandemic in the United States and globally. Overcoming these challenges will require optimization of the implementation of existing interventions for HIV prevention and treatment together with the continued development of new and innovative approaches that can be readily utilized by individuals with HIV and those at risk of infection. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  HIV; prevention; treatment

Year:  2019        PMID: 31646338      PMCID: PMC7188222          DOI: 10.1093/cid/ciz998

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3.

Authors:  Martin Markowitz; Agegnehu Gettie; Leslie St Bernard; Chasity D Andrews; Hiroshi Mohri; Amir Horowitz; Brooke F Grasperge; James L Blanchard; Tao Niu; Li Sun; Kerry Fillgrove; Daria J Hazuda; Jay A Grobler
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

2.  Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

Authors:  Benjamin R Bavinton; Angie N Pinto; Nittaya Phanuphak; Beatriz Grinsztejn; Garrett P Prestage; Iryna B Zablotska-Manos; Fengyi Jin; Christopher K Fairley; Richard Moore; Norman Roth; Mark Bloch; Catherine Pell; Anna M McNulty; David Baker; Jennifer Hoy; Ban Kiem Tee; David J Templeton; David A Cooper; Sean Emery; Anthony Kelleher; Andrew E Grulich
Journal:  Lancet HIV       Date:  2018-07-17       Impact factor: 12.767

3.  RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.

Authors:  Susa Coffey; Peter Bacchetti; Darpun Sachdev; Oliver Bacon; Diane Jones; Clarissa Ospina-Norvell; Sandra Torres; Elizabeth Lynch; Christy Camp; Remy Mercer-Slomoff; Sulggi Lee; Katerina Christopoulos; Christopher Pilcher; Ling Hsu; Chengshi Jin; Susan Scheer; Diane Havlir; Monica Gandhi
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

4.  Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Susan J Curry; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

Review 5.  Chemokine control of West Nile virus infection.

Authors:  Jean K Lim; Philip M Murphy
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

6.  Twenty Years Of Antiretroviral Therapy For People Living With HIV: Global Costs, Health Achievements, Economic Benefits.

Authors:  Steven S Forsythe; William McGreevey; Alan Whiteside; Maunank Shah; Joshua Cohen; Robert Hecht; Lori A Bollinger; Anthony Kinghorn
Journal:  Health Aff (Millwood)       Date:  2019-07       Impact factor: 6.301

Review 7.  HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

Review 8.  Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.

Authors:  Marina Caskey; Florian Klein; Michel C Nussenzweig
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

9.  A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection.

Authors:  Rajeev Gautam; Yoshiaki Nishimura; Natalie Gaughan; Anna Gazumyan; Till Schoofs; Alicia Buckler-White; Michael S Seaman; Bruce J Swihart; Dean A Follmann; Michel C Nussenzweig; Malcolm A Martin
Journal:  Nat Med       Date:  2018-04-16       Impact factor: 53.440

10.  Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.

Authors:  Prasanta K Dash; Rafal Kaminski; Ramona Bella; Hang Su; Saumi Mathews; Taha M Ahooyi; Chen Chen; Pietro Mancuso; Rahsan Sariyer; Pasquale Ferrante; Martina Donadoni; Jake A Robinson; Brady Sillman; Zhiyi Lin; James R Hilaire; Mary Banoub; Monalisha Elango; Nagsen Gautam; R Lee Mosley; Larisa Y Poluektova; JoEllyn McMillan; Aditya N Bade; Santhi Gorantla; Ilker K Sariyer; Tricia H Burdo; Won-Bin Young; Shohreh Amini; Jennifer Gordon; Jeffrey M Jacobson; Benson Edagwa; Kamel Khalili; Howard E Gendelman
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

View more
  5 in total

1.  An Update on Antiretroviral Therapy.

Authors:  Luis Menéndez-Arias; Samara Martín-Alonso; Estrella Frutos-Beltrán
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics.

Authors:  Robert W Eisinger; Andrea M Lerner; Anthony S Fauci
Journal:  J Infect Dis       Date:  2021-11-16       Impact factor: 5.226

3.  Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men Who Have Sex With Men Who Are Repeat Testers.

Authors:  Jennifer K Felner; Maria L Mittal; Martin Hoenigl; K Rivet Amico; David J Grelotti; Alex Eanes; Kristen Hess; Jessica Crawford; Laramie R Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2021-04-15       Impact factor: 3.771

Review 4.  Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections.

Authors:  Kaminee Maduray; Raveen Parboosing
Journal:  Biol Trace Elem Res       Date:  2020-10-07       Impact factor: 3.738

Review 5.  Pandemics and Burden of Stroke and Epilepsy in Sub-Saharan Africa: Experience from a Longstanding Health Programme.

Authors:  Massimo Leone; Fausto Ciccacci; Stefano Orlando; Sandro Petrolati; Giovanni Guidotti; Noorjehan Abdul Majid; Victor Tamba Tolno; JeanBaptiste Sagno; Darlington Thole; Fabio Massimo Corsi; Michelangelo Bartolo; Maria Cristina Marazzi
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.